Successful treatment of AIDS-associated, primary CNS lymphoma with rituximab- and methotrexate-based chemotherapy and autologous stem cell transplantation

Author： Wolf T.   Kiderlen T.   Atta J.   Stephan C.   Kann G.   Brodt H.-R.   Brandts C.  

Publisher： Springer Publishing Company

ISSN： 0300-8126

Source： Infection, Vol.42, Iss.2, 2014-04, pp. : 445-447

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Addition of Rituximab to High-Dose Methotrexate-Based Chemotherapy Improves Survival of Adults with Burkitt Lymphoma/Leukemia

By  

Acta Haematologica, Vol. 127, Iss. 2, 2011-12 ,pp. : 115-117

Karger

Access to resources Recommend Favorite

Anti-CD20 Monoclonal Antibody (Rituximab) and Cidofovir as Successful Treatment of an EBV-Associated Lymphoma with CNS Involvement

By  

Oncology Research and Treatment, Vol. 24, Iss. 5, 2001-10 ,pp. : 491-494

Karger

Access to resources Recommend Favorite

Phase I/II trial of vorinostat with rituximab, cyclophosphamide, etoposide and prednisone as palliative treatment for elderly patients with relapsed or refractory diffuse large B‐cell lymphoma not eligible for autologous stem cell transplantation

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 168, Iss. 5, 2015-03 ,pp. : 663-670

John Wiley & Sons Inc

Access to resources Recommend Favorite

High-Dose Chemotherapy and Autologous Hematopoietic Stem Cell Transplantation: The Lymphoma Experience and Its Potential Relevance to Solid Tumors

By  

Oncology, Vol. 58, Iss. 3, 2000-04 ,pp. : 198-206

Karger

Access to resources Recommend Favorite

Cytarabine, Ki‐67, and SOX11 in patients with mantle cell lymphoma receiving rituximab‐containing autologous stem cell transplantation during first remission

By  

CANCER, Vol. 119, Iss. 18, 2013-09 ,pp. : 3318-3325

John Wiley & Sons Inc

Access to resources Recommend Favorite